This Article Full Text Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van Zanten, G. H. Articles by Sixma, J. J. Search for Related Content PubMed PubMed Citation Articles by van Zanten, G. H. Articles by Sixma, J. J.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:1424-1431.)
© 1995 American Heart Association, Inc.

Articles

Recombinant Leech Antiplatelet Protein Specifically Blocks Platelet Deposition on Collagen Surfaces Under Flow Conditions

G. Henrita van Zanten; Thomas M. Connolly; Marion E. Schiphorst; Sytske de Graaf; Pieter J. Slootweg; Jan J. Sixma

From the Department of Haematology (G.H. van Z., M.E.S., S. de G., J.J.S.) and Pathology (P.J.S.), University Hospital Utrecht, the Netherlands, and from the Department of Biological Chemistry (T.M.C.), Merck Sharp & Dohme Research Laboratories, West Point, Pa.

Correspondence to Dr G.H. van Zanten, Department of Haematology, University Hospital Utrecht, P.O. Box 85500, 3508 GA Utrecht, the Netherlands. E-mail:jsixma@lab.azu.nl.

Abstract Salivary glands of the leech Haementeria officinalis contain a protein, leech antiplatelet protein (LAPP). This protein was cloned and expressed in yeast and blocks collagen-mediated platelet aggregation and the adhesion of platelets to collagen-coated plates under static conditions. In the current study we investigated the effect of rLAPP on platelet deposition to collagen and collagen-rich surfaces under flow conditions. rLAPP completely inhibited platelet adhesion on collagen types I, III, and IV with IC₅₀ values of 70, 600, and 90 nmol/L, respectively (shear rate=1600 s^-1). Approximately 10-fold more rLAPP was required to obtain a similar inhibition at a low shear rate of 375 s^-1. rLAPP caused a concentration-dependent inhibition of binding of ¹²⁵I–von Willebrand factor (vWF) to collagen type III and was able to displace prebound vWF even after 24 hours. Since platelet adhesion at low shear rate is less dependent on vWF than at high shear rate, this property of rLAPP may explain why less rLAPP is needed at high shear rate than at low shear rate to produce the same effect. Platelet adhesion to collagen type VI was only partially inhibited by rLAPP (maximal 44% with 3 µmol/L rLAPP). rLAPP also caused a pronounced inhibition of platelet deposition to cross sections of human atherosclerotic coronary arteries but had no effect on matrices of cultured human umbilical vein endothelial cells. rLAPP is a potent platelet adhesion inhibitor at high shear rate, which binds to collagen and works by inhibiting binding of vWF to collagen.

Key Words: rLAPP • collagen • von Willebrand factor • platelet adhesion

This article has been cited by other articles:

				E. Calvo, F. Tokumasu, O. Marinotti, J.-L. Villeval, J. M. C. Ribeiro, and I. M. B. Francischetti Aegyptin, a Novel Mosquito Salivary Gland Protein, Specifically Binds to Collagen and Prevents Its Interaction with Platelet Glycoprotein VI, Integrin {alpha}2beta1, and von Willebrand Factor J. Biol. Chem., September 14, 2007; 282(37): 26928 - 26938. [Abstract] [Full Text] [PDF]

				H. Depraetere, A. Viaene, S. Deroo, S. Vauterin, and H. Deckmyn Identification of Peptides, Selected by Phage Display Technology, That Inhibit von Willebrand Factor Binding to Collagen Blood, December 1, 1998; 92(11): 4207 - 4211. [Abstract] [Full Text] [PDF]